Prostaglandin E2 and Cancer: Insight into Tumor Progression and Immunity
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Prostaglandin E2 and Cancer: Insight into Tumor Progression and Immunity
Authors
Keywords
-
Journal
Biology-Basel
Volume 9, Issue 12, Pages 434
Publisher
MDPI AG
Online
2020-12-02
DOI
10.3390/biology9120434
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Effects of chronic low‐dose aspirin treatment on tumor prevention in three mouse models of intestinal tumorigenesis
- (2020) Nadine Rohwer et al. Cancer Medicine
- Tumor-derived prostaglandin E2 promotes p50 NF-κB-dependent differentiation of monocytic MDSC
- (2020) Chiara Porta et al. CANCER RESEARCH
- The role of myeloid-derived suppressor cells in increasing cancer stem-like cells and promoting PD-L1 expression in epithelial ovarian cancer
- (2020) Naoko Komura et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Effect of Low-dose and Standard-dose Aspirin on PGE2 Biosynthesis Among Individuals with Colorectal Adenomas: a Randomized Clinical Trial
- (2020) David A. Drew et al. Cancer Prevention Research
- ARS2/MAGL signaling in glioblastoma stem cells promotes self-renewal and M2-like polarization of tumor-associated macrophages
- (2020) Jinlong Yin et al. Nature Communications
- Association of aspirin, metformin, and statin use with gastric cancer incidence and mortality: A nationwide cohort study
- (2020) Mi Hee Cho et al. Cancer Prevention Research
- Astrocyte Signaling in the Neurovascular Unit After Central Nervous System Injury
- (2019) Lena Huang et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- GM-CSF Promotes Antitumor Immunity by Inducing Th9 Cell Responses
- (2019) Il-Kyu Kim et al. Cancer Immunology Research
- Use of nonsteroidal anti-inflammatory drugs predicts improved patient survival for PIK3CA-altered head and neck cancer
- (2019) Matthew L. Hedberg et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Nicotinamide Phosphoribosyltransferase Acts as a Metabolic Gate for Mobilization of Myeloid-Derived Suppressor Cells
- (2019) Cristina Travelli et al. CANCER RESEARCH
- Small‐molecule inhibition of prostaglandin E receptor 2 impairs cyclooxygenase‐associated malignant glioma growth
- (2019) Jiange Qiu et al. BRITISH JOURNAL OF PHARMACOLOGY
- Prostaglandin E2 as a potent therapeutic target for treatment of colon cancer
- (2019) Vahid Karpisheh et al. PROSTAGLANDINS & OTHER LIPID MEDIATORS
- Human Pancreatic Carcinoma-Associated Fibroblasts Promote Expression of Co-inhibitory Markers on CD4+ and CD8+ T-Cells
- (2019) Laia Gorchs et al. Frontiers in Immunology
- Prostaglandin E2 Induces MIR675-5p to Promote Colorectal Tumor Metastasis via Modulation of p53 Expression
- (2019) Bo Cen et al. GASTROENTEROLOGY
- Low-dose aspirin use and cancer-specific mortality: a meta-analysis of cohort studies
- (2019) Xianmin Wang et al. JOURNAL OF PUBLIC HEALTH
- Aspirin as an adjuvant treatment for cancer: feasibility results from the Add-Aspirin randomised trial
- (2019) Nalinie Joharatnam-Hogan et al. Lancet Gastroenterology & Hepatology
- Prostaglandin E2/EP Signaling in the Tumor Microenvironment of Colorectal Cancer
- (2019) Rei Mizuno et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- A review on mPGES-1 inhibitors: From preclinical studies to clinical applications
- (2019) Filip Bergqvist et al. PROSTAGLANDINS & OTHER LIPID MEDIATORS
- Trends in the contemporary incidence of colorectal cancer and patient characteristics in the United Kingdom: a population-based cohort study using The Health Improvement Network
- (2018) Lucía Cea Soriano et al. BMC CANCER
- NK Cells Stimulate Recruitment of cDC1 into the Tumor Microenvironment Promoting Cancer Immune Control
- (2018) Jan P. Böttcher et al. CELL
- The multifaceted link between inflammation and human diseases
- (2018) Peramaiyan Rajendran et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Role of prostanoids in gastrointestinal cancer
- (2018) Dingzhi Wang et al. JOURNAL OF CLINICAL INVESTIGATION
- Prostaglandin E2 receptor EP4 is involved in the cell growth and invasion of prostate cancer via the cAMP‑PKA/PI3K‑Akt signaling pathway
- (2018) Song Xu et al. Molecular Medicine Reports
- Prostaglandin E2 Inhibits Prostate Cancer Progression by Countervailing Tumor Microenvironment-Induced Impairment of Dendritic Cell Migration through LXRα/CCR7 Pathway
- (2018) Kuang Youlin et al. Journal of Immunology Research
- Celecoxib in Cancer Therapy and Prevention – Review
- (2018) Natalia Tolloczko - Iwaniuk et al. CURRENT DRUG TARGETS
- Gastric cancer: epidemiology, prevention, and therapy
- (2018) Marino Venerito et al. HELICOBACTER
- Aspirin associated with risk reduction of secondary primary cancer for patients with head and neck cancer: A population-based analysis
- (2018) Yu-Shan Lin et al. PLoS One
- Prostaglandin E2 Secreted by Thyroid Cancer Cells Contributes to Immune Escape Through the Suppression of Natural Killer (NK) Cell Cytotoxicity and NK Cell Differentiation
- (2018) Arum Park et al. Frontiers in Immunology
- Post‐diagnosis aspirin use and survival in veterans with head and neck cancer
- (2018) Catherine J. Lumley et al. HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK
- Prostaglandin E2 produced by myeloid-derived suppressive cells induces cancer stem cells in uterine cervical cancer
- (2018) Hiromasa Kuroda et al. Oncotarget
- Celecoxib in breast cancer prevention and therapy
- (2018) Jieqing Li et al. Cancer Management and Research
- PGE 2 synthesis and signaling in malignant transformation and progression of human hepatocellular carcinoma
- (2017) Shengbing Zang et al. HUMAN PATHOLOGY
- Aspirin and the prevention of a common disease: Colorectal cancer
- (2017) Felicita Andreotti et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Intracrine prostaglandin E2 pro-tumoral actions in prostate epithelial cells originate from non-canonical pathways
- (2017) Antonio Madrigal-Martínez et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Linking of mPGES-1 and iNOS activates stem-like phenotype in EGFR-driven epithelial tumor cells
- (2017) Erika Terzuoli et al. NITRIC OXIDE-BIOLOGY AND CHEMISTRY
- COX2/mPGES1/PGE2pathway regulates PD-L1 expression in tumor-associated macrophages and myeloid-derived suppressor cells
- (2017) Victor Prima et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Maintenance use of aspirin or other non-steroidal anti-inflammatory drugs (NSAIDs) and prostate cancer risk
- (2017) Yuanjun Ma et al. PROSTATE CANCER AND PROSTATIC DISEASES
- Indoleamine 2,3-dioxygenase: As a potential prognostic marker and immunotherapeutic target for hepatocellular carcinoma
- (2017) Kashif Asghar et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Role of Aspirin in Breast Cancer Survival
- (2017) Wendy Y. Chen et al. Current Oncology Reports
- PGE2/EP3/SRC signaling induces EGFR nuclear translocation and growth through EGFR ligands release in lung adenocarcinoma cells
- (2017) Lorenzo Bazzani et al. Oncotarget
- Fibroblastic reticular cells of the lymphoid tissues modulate T cell activation threshold during homeostasis via hyperactive cyclooxygenase-2/prostaglandin E2 axis
- (2017) Miao Yu et al. Scientific Reports
- Prostaglandin E2 Leads to the Acquisition of DNMT3A-Dependent Tolerogenic Functions in Human Myeloid-Derived Suppressor Cells
- (2017) Javier Rodríguez-Ubreva et al. Cell Reports
- Myeloid-Derived Suppressor Cells
- (2017) Dmitry I. Gabrilovich Cancer Immunology Research
- Constitutive IDO1 Expression in Human Tumors Is Driven by Cyclooxygenase-2 and Mediates Intrinsic Immune Resistance
- (2017) Marc Hennequart et al. Cancer Immunology Research
- Oncolytic Virus-Mediated Targeting of PGE 2 in the Tumor Alters the Immune Status and Sensitizes Established and Resistant Tumors to Immunotherapy
- (2016) Weizhou Hou et al. CANCER CELL
- PIK3CA Mutation, Aspirin Use after Diagnosis and Survival of Colorectal Cancer. A Systematic Review and Meta-analysis of Epidemiological Studies
- (2016) L. Paleari et al. CLINICAL ONCOLOGY
- Meta-analysis of aspirin use and risk of lung cancer shows notable results
- (2016) Friederike Hochmuth et al. EUROPEAN JOURNAL OF CANCER PREVENTION
- One Niche to Rule Both Maintenance and Loss of Stemness in HSCs
- (2016) Motonari Kondo IMMUNITY
- Aspirin and Cancer
- (2016) Paola Patrignani et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Dendritic cells as gatekeepers of tolerance
- (2016) Ari Waisman et al. Seminars in Immunopathology
- Prostaglandin E2 (PGE2) promotes proliferation and invasion by enhancing SUMO-1 activity via EP4 receptor in endometrial cancer
- (2016) Jieqi Ke et al. TUMOR BIOLOGY
- Linking microsomal prostaglandin E synthase-1/PGE-2 pathway with miR-15a and -186 expression: Novel mechanism of VEGF modulation in prostate cancer
- (2016) Erika Terzuoli et al. Oncotarget
- Differential expression of cyclooxygenase-2 in metastatic melanoma affects progression free survival
- (2016) Elisabetta Panza et al. Oncotarget
- IFN -Dependent Interactions between ICAM-1 and LFA-1 Counteract Prostaglandin E2-Mediated Inhibition of Antitumor CTL Responses
- (2016) F. S. Basingab et al. Cancer Immunology Research
- Aspirin in the Treatment of Cancer: Reductions in Metastatic Spread and in Mortality: A Systematic Review and Meta-Analyses of Published Studies
- (2016) Peter C. Elwood et al. PLoS One
- The cancer burden attributable to biologic agents
- (2015) David Schottenfeld et al. ANNALS OF EPIDEMIOLOGY
- Association between aspirin use and mortality in breast cancer patients: a meta-analysis of observational studies
- (2015) Shanliang Zhong et al. BREAST CANCER RESEARCH AND TREATMENT
- Prostaglandin E2 and the EP receptors in malignancy: possible therapeutic targets?
- (2015) G O'Callaghan et al. BRITISH JOURNAL OF PHARMACOLOGY
- Aspirin and nonsteroidal anti-inflammatory drugs after but not before diagnosis are associated with improved breast cancer survival: a meta-analysis
- (2015) Xuan-zhang Huang et al. CANCER CAUSES & CONTROL
- Aspirin and other non-steroidal anti-inflammatory drug prescriptions and survival after the diagnosis of head and neck and oesophageal cancer
- (2015) Tatiana V Macfarlane et al. Cancer Epidemiology
- mPGES-1 in prostate cancer controls stemness and amplifies epidermal growth factor receptor-driven oncogenicity
- (2015) Federica Finetti et al. ENDOCRINE-RELATED CANCER
- Cyclooxygenase-2 inhibitors in lung cancer treatment: Bench to bed
- (2015) Rui Liu et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Prostaglandin E2 Promotes Colorectal Cancer Stem Cell Expansion and Metastasis in Mice
- (2015) Dingzhi Wang et al. GASTROENTEROLOGY
- Direct Melanoma Cell Contact Induces Stromal Cell Autocrine Prostaglandin E2-EP4 Receptor Signaling That Drives Tumor Growth, Angiogenesis, and Metastasis
- (2015) Masaki Inada et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Lipopolysaccharide induces inflammation and facilitates lung metastasis in a breast cancer model via the prostaglandin E2-EP2 pathway
- (2015) SHANCHENG LI et al. Molecular Medicine Reports
- Role of microsomal prostaglandin E synthase-1 (mPGES-1)-derived prostaglandin E2 in colon carcinogenesis
- (2015) Yuka Sasaki et al. PROSTAGLANDINS & OTHER LIPID MEDIATORS
- Prostaglandin E receptor 4 (EP4) promotes colonic tumorigenesis
- (2015) Jian Chang et al. Oncotarget
- PGE2-induced colon cancer growth is mediated by mTORC1
- (2014) Marc Dufour et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Aspirin intake and breast cancer survival – a nation-wide study using prospectively recorded data in Sweden
- (2014) Michelle D Holmes et al. BMC CANCER
- Over-expression of COX-2 mRNA in colorectal cancer
- (2014) Hennie MJ Roelofs et al. BMC GASTROENTEROLOGY
- Aspirin use and survival after the diagnosis of breast cancer: a population-based cohort study
- (2014) D M Fraser et al. BRITISH JOURNAL OF CANCER
- Aspirin and non-steroidal anti-inflammatory drug use and the risk of upper aerodigestive tract cancer
- (2014) T V Macfarlane et al. BRITISH JOURNAL OF CANCER
- Activated cytotoxic lymphocytes promote tumor progression by increasing the ability of 3LL tumor cells to mediate MDSC chemoattraction via Fas signaling
- (2014) Fei Yang et al. Cellular & Molecular Immunology
- Inhibition of Tumor-Derived Prostaglandin-E2 Blocks the Induction of Myeloid-Derived Suppressor Cells and Recovers Natural Killer Cell Activity
- (2014) Y. Mao et al. CLINICAL CANCER RESEARCH
- Prostanoid induces premetastatic niche in regional lymph nodes
- (2014) Fumihiro Ogawa et al. JOURNAL OF CLINICAL INVESTIGATION
- Vascular endothelial growth factor plays a critical role in the formation of the pre-metastatic niche via prostaglandin E2
- (2014) SHILI LIU et al. ONCOLOGY REPORTS
- Prostaglandin E2 accelerates invasion by upregulating Snail in hepatocellular carcinoma cells
- (2014) Min Zhang et al. TUMOR BIOLOGY
- Low-dose aspirin use and cancer characteristics: a population-based cohort study
- (2013) F Jonsson et al. BRITISH JOURNAL OF CANCER
- Melanoma-Educated CD14 + Cells Acquire a Myeloid-Derived Suppressor Cell Phenotype through COX-2–Dependent Mechanisms
- (2013) Yumeng Mao et al. CANCER RESEARCH
- Reciprocal crosstalk between dendritic cells and natural killer cells under the effects of PGE2 in immunity and immunopathology
- (2013) Hedi Harizi Cellular & Molecular Immunology
- The ratio between dendritic cells and T cells determines whether prostaglandin E2 has a stimulatory or inhibitory effect
- (2013) Alexander Shimabukuro-Vornhagen et al. CELLULAR IMMUNOLOGY
- Expression of microsomal prostaglandin E2 synthase-1 and its role in human hepatocellular carcinoma
- (2013) Shengbing Zang et al. HUMAN PATHOLOGY
- Prostaglandin E2 promotes liver cancer cell growth by the upregulation of FUSE-binding protein 1 expression
- (2013) JUAN MA et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- T and NK cells: two sides of tumor immunoevasion
- (2013) Doriana Fruci et al. Journal of Translational Medicine
- Colorectal carcinoma-derived fibroblasts modulate natural killer cell phenotype and antitumor cytotoxicity
- (2013) Tuanjie Li et al. MEDICAL ONCOLOGY
- Genetic deletion of microsomal prostaglandin E synthase-1 suppresses mouse mammary tumor growth and angiogenesis
- (2013) Louise R. Howe et al. PROSTAGLANDINS & OTHER LIPID MEDIATORS
- A prostaglandin E (PGE) receptor EP4 antagonist protects natural killer cells from PGE2-mediated immunosuppression and inhibits breast cancer metastasis
- (2013) Xinrong Ma et al. OncoImmunology
- HT-29 human colon cancer cell proliferation is regulated by cytosolic phospholipase A2α dependent PGE2 via both PKA and PKB pathways
- (2012) Liz Kisslov et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS
- Aspirin but not ibuprofen use is associated with reduced risk of prostate cancer: a PLCO Study
- (2012) F M Shebl et al. BRITISH JOURNAL OF CANCER
- Melanoma Cells Inhibit Natural Killer Cell Function by Modulating the Expression of Activating Receptors and Cytolytic Activity
- (2012) G. Pietra et al. CANCER RESEARCH
- Modulation of Host Natural Killer Cell Functions in Breast Cancer via Prostaglandin E2 Receptors EP2 and EP4
- (2012) Dawn M. Holt et al. JOURNAL OF IMMUNOTHERAPY
- Effects of regular aspirin on long-term cancer incidence and metastasis: a systematic comparison of evidence from observational studies versus randomised trials
- (2012) Annemijn M Algra et al. LANCET ONCOLOGY
- Global burden of cancers attributable to infections in 2008: a review and synthetic analysis
- (2012) Catherine de Martel et al. LANCET ONCOLOGY
- The role of aspirin in cancer prevention
- (2012) Michael J. Thun et al. Nature Reviews Clinical Oncology
- Aspirin Use, TumorPIK3CAMutation, and Colorectal-Cancer Survival
- (2012) Xiaoyun Liao et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pharmacological Inhibition of Microsomal Prostaglandin E Synthase-1 Suppresses Epidermal Growth Factor Receptor-Mediated Tumor Growth and Angiogenesis
- (2012) Federica Finetti et al. PLoS One
- Role of medical history and medication use in the aetiology of upper aerodigestive tract cancers in Europe: the ARCAGE study
- (2011) T. V. Macfarlane et al. ANNALS OF ONCOLOGY
- Positive feedback between PGE2 and COX2 redirects the differentiation of human dendritic cells toward stable myeloid-derived suppressor cells
- (2011) N. Obermajer et al. BLOOD
- Prostaglandin catabolic enzymes as tumor suppressors
- (2011) Hsin-Hsiung Tai CANCER AND METASTASIS REVIEWS
- Non-steroidal anti-inflammatory drug and aspirin use and the risk of head and neck cancer: a systematic review
- (2011) Jessica C. Wilson et al. CANCER CAUSES & CONTROL
- Prostaglandin E2 (PGE2) suppresses natural killer cell function primarily through the PGE2 receptor EP4
- (2011) Dawn Holt et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Selective PGE2 Suppression Inhibits Colon Carcinogenesis and Modifies Local Mucosal Immunity
- (2011) M. Nakanishi et al. Cancer Prevention Research
- Lung Cancer Chemoprevention with Celecoxib in Former Smokers
- (2011) Jenny T. Mao et al. Cancer Prevention Research
- COX-2 Blockade Suppresses Gliomagenesis by Inhibiting Myeloid-Derived Suppressor Cells
- (2011) M. Fujita et al. CANCER RESEARCH
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- M2 Macrophages Induced by Prostaglandin E2 and IL-6 from Cervical Carcinoma Are Switched to Activated M1 Macrophages by CD4+ Th1 Cells
- (2011) M. Heusinkveld et al. JOURNAL OF IMMUNOLOGY
- EGFR signaling upregulates expression of microsomal prostaglandin E synthase-1 in cancer cells leading to enhanced tumorigenicity
- (2011) S Donnini et al. ONCOGENE
- PGE2 inhibits natural killer and γδ T cell cytotoxicity triggered by NKR and TCR through a cAMP-mediated PKA type I-dependent signaling
- (2010) Ludovic Martinet et al. BIOCHEMICAL PHARMACOLOGY
- Pre-surgical study of the biological effects of the selective cyclo-oxygenase-2 inhibitor celecoxib in patients with primary breast cancer
- (2010) Lesley-Ann Martin et al. BREAST CANCER RESEARCH AND TREATMENT
- Nonsteroidal Anti-Inflammatory Drugs and Risk for Ovarian and Endometrial Cancers in the Iowa Women's Health Study
- (2010) A. E. Prizment et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Biological Activity of Celecoxib in the Bronchial Epithelium of Current and Former Smokers
- (2010) E. S. Kim et al. Cancer Prevention Research
- Inhibition of Hypoxia Inducible Factor-1 by Dihydroxyphenylethanol, a Product from Olive Oil, Blocks Microsomal Prostaglandin-E Synthase-1/Vascular Endothelial Growth Factor Expression and Reduces Tumor Angiogenesis
- (2010) E. Terzuoli et al. CLINICAL CANCER RESEARCH
- Role of prostanoid IP and EP receptors in mediating vasorelaxant responses to PGI2 analogues in rat tail artery: Evidence for Gi/o modulation via EP3 receptors
- (2010) Nelson N. Orie et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Prostaglandin E2 Signaling and Bacterial Infection Recruit Tumor-Promoting Macrophages to Mouse Gastric Tumors
- (2010) Hiroko Oshima et al. GASTROENTEROLOGY
- Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trials
- (2010) Peter M Rothwell et al. LANCET
- Molecular mechanisms regulating myeloid-derived suppressor cell differentiation and function
- (2010) Thomas Condamine et al. TRENDS IN IMMUNOLOGY
- Prostaglandin E 2 Primes the Angiogenic Switch via a Synergic Interaction With the Fibroblast Growth Factor-2 Pathway
- (2009) Federica Finetti et al. CIRCULATION RESEARCH
- Aspirin Use and the Risk of Gastric Cancer: A Meta-Analysis
- (2009) Ping Yang et al. DIGESTIVE DISEASES AND SCIENCES
- Aspirin for the Chemoprevention of Colorectal Adenomas: Meta-analysis of the Randomized Trials
- (2009) Bernard F. Cole et al. JNCI-Journal of the National Cancer Institute
- Aspirin and non-steroidal anti-inflammatory drugs for cancer prevention: an international consensus statement
- (2009) Jack Cuzick et al. LANCET ONCOLOGY
- 15-Hydroxyprostaglandin dehydrogenase inactivation as a mechanism of resistance to celecoxib chemoprevention of colon tumors
- (2009) M. Yan et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Aspirin: Promise and Resistance in the New Millennium
- (2008) Carlo Patrono et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Human natural killer cells
- (2008) M. A. Caligiuri BLOOD
- Celecoxib and exemestane versus placebo and exemestane in postmenopausal metastatic breast cancer patients: a double-blind phase III GINECO study
- (2008) C. Falandry et al. BREAST CANCER RESEARCH AND TREATMENT
- Association between NSAIDs use and breast cancer risk: a systematic review and meta-analysis
- (2008) Ya-shuang Zhao et al. BREAST CANCER RESEARCH AND TREATMENT
- Antagonism of the prostaglandin E receptor EP4 inhibits metastasis and enhances NK function
- (2008) Namita Kundu et al. BREAST CANCER RESEARCH AND TREATMENT
- Genetic Deletion of mPGES-1 Suppresses Intestinal Tumorigenesis
- (2008) M. Nakanishi et al. CANCER RESEARCH
- Prostaglandin E2 Regulates Tumor Angiogenesis in Prostate Cancer
- (2008) S. Jain et al. CANCER RESEARCH
- Induction of myeloid-derived suppressor cells by tumor exosomes
- (2008) Xiaoyu Xiang et al. INTERNATIONAL JOURNAL OF CANCER
- Celecoxib anti-aromatase neoadjuvant (CAAN) trial for locally advanced breast cancer
- (2008) Louis Wing-Cheong Chow et al. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started